Phase II: University of Minnesota Masonic Cancer Center Follow-up Study

Reduction in Biomarkers From Smoking VLN Cigarettes for 6 Weeks

Phase II Trial

(Hatsukami et al. – 2013 Cancer Epidemiol Biomarkers Prev 22:1015-24)